• 1
    Kim WR. Epidemiology of hepatitis B in the United States. Hepatology 2009;49(5 Suppl):S28-S34.
  • 2
    Wasley A, Kruszon-Moran D, Kuhnert W, Simard EP, Finelli L, McQuillan G, et al. The prevalence of hepatitis B virus infection in the United States in the era of vaccination. J Infect Dis 2010;202:192-201.
  • 3
    Goldstein ST, Zhou F, Hadler SC, Bell BP, Mast EE, Margolis HS. A mathematical model to estimate global hepatitis B disease burden and vaccination impact. Int J Epidemiol 2005;34:1329-1339.
  • 4
    Lavanchy D. Worldwide epidemiology of HBV infection, disease burden, and vaccine prevention. J Clin Virol 2005;34(Suppl 1):S1-S3.
  • 5
    Mast EE, Weinbaum CM, Fiore AE, Alter MJ, Bell BP, Finelli L, et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults. MMWR Recomm Rep 2006;55( RR-16):1-33; quiz CE1-4.
  • 6
    Mast EE, Margolis HS, Fiore AE, Brink EW, Goldstein ST, Wang SA, et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP). Part I. Immunization of infants, children, and adolescents. MMWR Recomm Rep 2005;54( RR-16):1-31.
  • 7
    Weinbaum CM, Williams I, Mast EE, Wang SA, Finelli L, Wasley A, et al. Recommendations for identification and public health management of persons with chronic hepatitis B virus infection. MMWR Recomm Rep 2008;57( RR-8):1-20.
  • 8
    Eckman MH, Kaiser TE, Sherman KE. The cost effectiveness of screening for chronic hepatitis B infection in the United States. Clin Infect Dis 2011;52:1294-1306.
  • 9
    Grytdal SP, Liao Y, Chen R, Grigg-Saito D, Kagawa-Singer M, Liang S, et al. Hepatitis B testing and vaccination among Vietnamese- and Cambodian-Americans. J Community Health 2009;34:173-180.
  • 10
    Blendon RJ, Aiken LH, Freeman HE, Corey CR. Access to medical care for black and white Americans. A matter of continuing concern. JAMA 1989;261:278-281.
  • 11
    Liao Y, Bang D, Cosgrove S, Dulin R, Harris Z, Taylor A, et al. Surveillance of health status in minority communities — Racial and Ethnic Approaches to Community Health Across the U.S. (REACH U.S.) Risk Factor Survey, United States, 2009. MMWR Surveill Summ 2011;60:1-44.
  • 12
    Taylor VM, Talbot J, Do HH, Liu Q, Yasui Y, Jackson JC, et al. Hepatitis B knowledge and practices among Cambodian Americans. Asian Pac J Cancer Prev 2011;12:957-961.
  • 13
    Coronado GD, Taylor VM, Tu SP, Yasui Y, Acorda E, Woodall E, et al. Correlates of hepatitis B testing among Chinese Americans. J Community Health 2007;32:379-390.
  • 14
    Shiau R, Bove F, Henne J, Zola J, Fang T, Fernyak S. Using survey results regarding hepatitis B knowledge, community awareness and testing behavior among asians to improve the San Francisco Hep B Free Campaign. J Community Health 2012;37:350-364.
  • 15
    Hwang JP, Mohseni M, Gor BJ, Wen S, Guerrero H, Vierling JM. Hepatitis B and hepatitis C prevalence and treatment referral among Asian Americans undergoing community-based hepatitis screening. Am J Public Health 2010;100(Suppl 1):S118-S124.
  • 16
    IOM (Institute of Medicine). Hepatitis and Liver Cancer: A National Strategy for Prevention and Control of Hepatitis B and C. Colvin HM, Mitchell AE, eds. Washington, DC: National Academies Press; 2010.
  • 17
    Choe JH, Taylor VM, Yasui Y, Burke N, Nguyen T, Acorda E, et al. Health care access and sociodemographic factors associated with hepatitis B testing in Vietnamese American men. J Immigr Minor Health 2006;8:193-201.
  • 18
    Hu KQ, Pan CQ, Goodwin D. Barriers to screening for hepatitis B virus infection in Asian Americans. Dig Dis Sci 2011;56:3163-3171.
  • 19
    Bailey MB, Shiau R, Zola J, Fernyak SE, Fang T, So SK, et al. San Francisco hep B free: a grassroots community coalition to prevent hepatitis B and liver cancer. J Community Health 2011;36:538-551.
  • 20
    Pollack H, Wang S, Wyatt L, Peng CH, Wan K, Trinh-Shevrin C, et al. A comprehensive screening and treatment model for reducing disparities in hepatitits B. Health Aff 2011;30:1974-1983.
  • 21
    Mitchell T, Armstrong GL, Hu DJ, Wasley A, Painter JA. The increasing burden of imported chronic hepatitis B — United States, 1974-2008. PlosOne 2011;6:e27717
  • 22
    Kowdley KV, Wang CC, Welch S, Roberts H, Brosgart CL. Prevalence of chronic hepatitis B among foreign-born persons living in the United States by country of origin. Hepatology 2012;56:422-433.
  • 23
    World Health Organization. Hepatitis B vaccines. Wkly Epidemiol Rec 2009;84:405-419. Available at: (accessed May 21, 2012).
  • 24
    Chang ET, Nguyen BH, So SK. Attitudes toward hepatitis B and liver cancer prevention among Chinese Americans in the San Francisco Bay Area, California. Asian Pac J Cancer Prev 2008;9:605-613.
  • 25
    Ferrante JM, Winston DG, Chen PH, de la Torre AN. Family physicians' knowledge and screening of chronic hepatitis and liver cancer. Fam Med 2008;40:345-351.
  • 26
    Keeffe EB, Dieterich DT, Han SH, Jacobson IM, Martin P, Schiff ER, et al. A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: 2008 update. Clin Gastroenterol Hepatol 2008;6:1315-1341.
  • 27
    Liaw YF, Leung N, Kao JH, Piratvisuth T, Gane E, Han KH, et al. Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update. Hepatol Int 2008;2:263-283.
  • 28
    European Association For The Study Of The Liver (EASL). Clinical practice guidelines: management of chronic hepatitis B. J Hepatol 2009;50:227-242.
  • 29
    Chen CJ, Yang HI, Iloeje UH. Hepatitis B virus DNA levels and outcomes in chronic hepatitis B. Hepatology 2009;49(5 Suppl):S72-S84.
  • 30
    Iloeje UH, Yang HI, Jen CL, Su J, Wang LY, You SL, et al. Risk and predictors of mortality associated with chronic hepatitis B infection. Clin Gastroenterol Hepatol 2007;5:921-931.
  • 31
    Iloeje UH, Yang HI, Su J, Jen CL, You SL, Chen CJ. Predicting cirrhosis risk based on the level of circulating hepatitis B viral load. Gastroenterology 2006;130:678-686.